Clinical Trials List
Protocol NumberBLI-1401-2-01
Not yet recruiting
2016-09-15 - 2018-09-15
Others
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chih-Ming Chou Division of Hematology & Oncology
- Chia-Lun Chang Division of Hematology & Oncology
- Mao-Chih Hsieh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHIN-SHENG HUNG Division of General Surgery
- 夏和雄 Division of Hematology & Oncology
- Cheng-Jeng Tai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Hong Cheng Division of Hematology & Oncology
- 蘇智銘 Division of General Surgery
- 蘇勇誠 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24-32 participants
-
Global
0 participants
